- Oct 13
Blocking Immune Molecule Prolongs Survival in Models of the Most Aggressive Childhood Cancer
Researchers demonstrate that TIM-3 inhibition promotes immune memory in diffuse intrinsic stem glioma (DIPG). Read more:...
- Aug 21
New drug candidate nearly doubles survival for patients with aggressive childhood brain tumors
For the first time, researchers have found a potential drug candidate that improved outcomes for patients with a type of childhood brain...
- May 30
Drug combination discovery may extend life expectancy of children with brain cancer
Newcastle and Hunter-based researchers have discovered a drug combination that could improve the life expectancy of children with brain...
- May 11
Advanced immunotherapy treatment may hold promise for children with brain cancer
WEHI researchers have found promise in treating DIPG with an innovative new immunotherapy treatment, called CAR T therapy. Read more:...
- Apr 20
Localized delivery of CAR T cells to treat children with brain tumors
Advancements in CAR T cell delivery and B7-H3 targeting enabled researchers to conduct an exploratory clinical trial to evaluate B7-H3...
- Apr 12
From tragedy, a potential pediatric cancer treatment
Diffuse intrinsic pontine glioma (DIPG) is a lethal pediatric brain cancer that often kills within a year of diagnosis. Surgery is almost...
- Feb 10
Children’s Cancer Institute begins trial for childhood brain cancer therapy
The trial will use the child’s own immune system for specifically targeting the Diffuse Intrinsic Pontine Glioma. Read more:...
- Dec 14, 2022
Research opens a window into understanding deadly brain tumors
Formerly known as diffuse intrinsic pontine gliomas, diffuse midline gliomas (DMGs) are highly aggressive tumors found in the midline...
- Jul 5, 2022
Harnessing a virus to fight a killer brain tumor in kids
A therapy that uses a virus to kill tumor cells can be safely given to children with a rare, incurable form of brain cancer, an early...
- Feb 9, 2022
From loss comes hope: Pediatric brain tumor treatment shows promise
Today a group of Stanford scientists who have spent the past decade unlocking the glioma's secrets are publishing data in Nature from ...